Breaking News

Weekly News Quiz: March 2, 2023



Two new RSV vaccine candidates, made by Pfizer and GlaxoSmithKline, could become the world’s first approved shots against the common respiratory syncytial virus (RSV). The FDA, which typically follows the committee’s recommendations, is expected to decide on approval in May, ahead of RSV’s typical winter surge.



Shared From Source link Breaking News

Leave a Reply

Your email address will not be published. Required fields are marked *